ENB Therapeutics Closes Series A Round of Funding

by | Sep 21, 2018 | Press Releases

New York, NY, September 20, 2018: ENB Therapeutics Inc., a biopharmaceutical company pioneering pathways in endothelin-based oncologics, today announced that it has closed its Series A private equity financing. Proceeds from the financing will be used to advance the...